Experimental therapy of cardiac remodeling with quercetin-containing drugs

Authors

  • M.A. Kuzmenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • V.B. Pavlyuchenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • L.V. Tumanovskaya Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • V.E. Dosenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine
  • A.A. Moybenko Bogomoletz Institute of Physiology, 4, Bogomoletz str., Kyiv, 01024, Ukraine

Keywords:

cardiac remodeling, bioflavonoids, fibrosis, cardiac function

Abstract

It was shown that continuous beta-adrenergic hyperstimulation resulted in cardiac function disturbances and fibrosis of cardiac tissue. Treatment with quercetin-containing drugs, particularly, water-soluble corvitin and tableted quertin exerted favourable effect on cardiac hemodynamics, normalized systolic and diastolic function in cardiac remodeling, induced by sustained beta-adrenergic stimulation. It was estimated that conducted experimental therapy limited cardiac fibrosis area almost three-fold, that could be associated with first and foremost improved cardiac distensibility, characteristics of diastolic and also pump function in cardiac remodeling.

Downloads

Download data is not yet available.

Downloads

Published

19-06-2013

Issue

Section

Original research

How to Cite

Kuzmenko M., Pavlyuchenko V., Tumanovskaya L., et al. Experimental therapy of cardiac remodeling with quercetin-containing drugs. Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 2013; 57(2): 17–22. Accessed May 4, 2026 https://pfiet.ru/article/view/5339

Similar Articles

1-10 of 78

You may also start an advanced similarity search for this article.